$NUVB Cashflow Statement | Understand Stock

$NUVB

$4.55 +$0.04 (0.89%) Close

$NUVB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Issuance of common stock for in-process research and development expense
Stock-based compensation
Depreciation and amortization
Non-cash lease expense
Non-cash interest on revenue interest financing agreement
Amortization of issuance costs
Change in fair value of warrant liability
Net amortization on marketable securities
Realized loss on marketable securities
Amortization of premium and discounts on marketable securities
Realized loss (gain) on marketable securities
Net loss on disposal of property and equipment
Unrealized foreign currency transaction loss
Acquired in-process research and development

Change in operating assets and liabilities
Accounts receivable
Prepaid expenses and other current assets
Inventory
Interest receivable on marketable securities
Lease security deposit
Other non-current assets
Accounts payable
Contract liabilities
Accrued expenses
Deferred rent

Net cash used in operating activities
Cash flow from investing activities:
Cash acquired from AnHeart acquisition
Transaction costs related to AnHeart acquisition
Purchases of marketable securities
Proceeds from sale of marketable securities
Purchases of property and equipment
Proceeds from sale of property and equipment
Cash paid for capitalized market approval intangibles
Net cash provided by investing activities
Cash flow from financing activities:
Proceeds from the Merger, net of offering costs paid
Proceeds from borrowings, net of issuance costs
Proceeds from revenue interest financing agreement
Payments on borrowings
Payments on debt issuance costs
Payments on Finance Agreement
Proceeds from issuance of common stock under ESPP
Proceeds from exercises of options
Net cash provided by financing activities

Effect of foreign exchange rate changes on cash and cash equivalents
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of the period
Cash and cash equivalents, end of the period
Supplemental disclosure of cash flow information:
Cash paid for interest
Cash paid for tax
Non-cash operating activities:
Right-of-use asset recognized
Operating lease liability recognized
Non-cash investing activities:
Issuance of common stock for in-process research and development
Deferred financing costs in accounts payable and accrued expenses
Issuance of common stock related to the AnHeart acquisition
Issuance of convertible preferred stock related to the AnHeart acquisition
Issuance of warrants related to the AnHeart acquisition
Issuance of replacement awards related to the AnHeart acquisition

Comments